Product
An artificial intelligence algorithm bio-information analysis (ECG) platform service based on the convergence of medical and advanced IT technologies.
The risk of arrhythmia, atrial fibrilation, stroke is 5 times higher and the death rate can be 2 time higher, so early detection is a number one priority. CardiaI is the world second CE-certified product that can read the heart desease accurately within 30 seconds using AI diagnosis, CardiaI is also an useful product that provide the detail of desease for professional diagnosis and displaying the artificial intelligence analysis on webviewers and mobile devices.
CardiaI
Portability
Self-diagnosis and data acquisition as soon as abnormal symptoms appear
Accuracy
Provides high accuracy for arrhythmia analysis by applying image and waveform analysis algorithms.
Reliability
FDA Approves Grade 3 Medical Device, Gets CE Certification, Completes Patent Registration for Technology and Design
Real-time analysis
Immediately check analysis results and provide detailed analysis results to help medical personnel diagnose
To make requests for further information, contact us
Call Us For Purchase Inquiry
KR
82 70-8866-4492
ID
